One study showed that in non-dialysis DKD, neither eGFR nor albuminuria influenced plasma PCSK9 levels, but PCSK9 plasma levels were elevated in patients on lipid-lowering therapy [47]. Here, PCSK9 is linked to diabetic kidney disease.